Search from website

PEGS2022 Icosagen Therapeutics TALK: Functional mABs against multi-span transmembrane proteins, a case study by Senior Researcher Siret Tahk.

#PEGS2022 Icosagen Therapeutics TALK: Functional mAbs against multi-span transmembrane proteins, a case study by Senior Researcher Siret Tahk,on our internal therapeutic pipeline. Monday, Nov. 14, from 13:15 - 13:45, room Zafir. 

Icosagen has developed a wide expertise and array of technologies in antibody development, protein engineering, protein production and functional characterization over the past 20 years. The integration of this profound protein development expertise, up to stable cell line development and GMP manufacturing capabilities, now cumulates also in Icosagen Therapeutics and our own mAb pipeline. 

Meet us at booth #15 to get in touch in #PEGSEurope and follow Icosagen Therapeutics page on LinkedIn to keep up with our latest developments.  

#antibodydiscovery#GPCR#integral#membrane#protein#antibodies#therapeutic#pipeline

error:
Shopping Cart